69 growth-stage medtech investors in the US
We list 69 growth-stage medtech investors in the US as of November 2026: each has an SEC filing on file, and the list was last checked on 6 Nov 2026. The cities with the most head offices on this list are New York (9), Boston (5) and Menlo Park (4).
Top 5 growth-stage medtech investors in the US, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (30: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (20; half of that when the sector is stated only), stage focus (15: all of it when growth-stage is the only stage the firm states, split evenly when it states more), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (12) and completeness of the public record (8). Stage and regional focus are our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
JSTAR Capital
Type: VC firm · HQ: Austin, TX · Stages: Growth · Focus: Medtech, Healthtech, AI, Fintech · Latest activity: New fund, Aug 2026 · Fund size on file: $100M (SEC Form D, 2025)
Latest fund filing dated Aug 2026; $100M fund on file (SEC Form D, 2025); 62% of its observed portfolio is medtech and medical devices; backs growth-stage; 8 named decision-makers on file.
Town Hall Ventures
Type: VC firm · HQ: New York, NY · Stages: Growth · Focus: Medtech, Healthtech, Impact · Latest activity: New deal, Sep 2026 · Fund size on file: $400M (SEC Form D, 2025)
Dated new deal in Sep 2026; $400M fund on file (SEC Form D, 2025); states medtech and medical devices as a focus; backs growth-stage; names the US as where it invests; 8 named decision-makers on file.
Echo Health Ventures
Type: Corporate VC · HQ: Durham, NC · Stages: Growth · Focus: Medtech, Healthtech · Latest activity: Portfolio news, Sep 2026 · Private fund assets: $518M (SEC Form ADV)
Portfolio news dated Sep 2026; $518M on file (SEC Form ADV); 77% of its observed portfolio is medtech and medical devices; backs growth-stage; 2 named decision-makers on file.
Longitude Venture Partners
Type: VC firm · HQ: Menlo Park, CA · Stages: Growth · Focus: Medtech, Healthtech, Biotech · Latest activity: New deal, Jun 2026 · Fund size on file: $600M (SEC Form D, 2022)
Dated new deal in Jun 2026; $600M fund on file (SEC Form D, 2022); states medtech and medical devices as a focus; backs growth-stage; names the US as where it invests; 8 named decision-makers on file.
MVM Partners LLP
Type: VC firm · HQ: Boston, MA · Stages: Growth · Focus: Medtech, Healthtech, Biotech · Latest activity: Portfolio news, Jun 2026 · Private fund assets: $1.0B (SEC Form ADV)
Portfolio news dated Jun 2026; $1.0B on file (SEC Form ADV); states medtech and medical devices as a focus; backs growth-stage; names the US as where it invests.
First 25 of 69 growth-stage medtech investors in the US
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| JSTAR Capital | VC firm | Austin, TX | Growth | Medtech, Healthtech, AI, Fintech | New fund, Aug 2026 | $100M (SEC Form D, 2025) | 4 Nov 2026 | 8 names · Unlock |
| Town Hall Ventures | VC firm | New York, NY | Growth | Medtech, Healthtech, Impact | New deal, Sep 2026 | $400M (SEC Form D, 2025) | 5 Nov 2026 | 8 names · Unlock |
| Echo Health Ventures | Corporate VC | Durham, NC | Growth | Medtech, Healthtech | Portfolio news, Sep 2026 | $518M (SEC Form ADV) | 5 Nov 2026 | 2 names · Unlock |
| Longitude Venture Partners | VC firm | Menlo Park, CA | Growth | Medtech, Healthtech, Biotech | New deal, Jun 2026 | $600M (SEC Form D, 2022) | 5 Nov 2026 | 8 names · Unlock |
| MVM Partners LLP | VC firm | Boston, MA | Growth | Medtech, Healthtech, Biotech | Portfolio news, Jun 2026 | $1.0B (SEC Form ADV) | 5 Nov 2026 | No contact on file |
| Khosla Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Growth | Medtech, AI, Consumer, B2B | New fund, Aug 2026 | $1.9B (SEC Form D, 2025) | 4 Nov 2026 | 8 names · Unlock |
| Bioventures Investors | VC firm | Westborough, MA | Growth | Medtech, Healthtech, Future of Work, Fintech | New deal, Apr 2025 | $350M (SEC Form D, 2020) | 5 Nov 2026 | 8 names, firm email · Unlock |
| Transformation Capital | VC firm | Boston, MA | Growth | Medtech, Healthtech | New fund, Sep 2026 | $800M (SEC Form D, 2022) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Treo Ventures | VC firm | Reno, NV | Growth | Medtech, Healthtech | Portfolio news, Apr 2025 | $150M (SEC Form D, 2022) | 5 Nov 2026 | 4 names · Unlock |
| Portfolia | Fund manager | San Mateo, CA | Growth | Medtech, Healthtech, Media, Fintech | New fund, Apr 2026 | $6M (SEC Form D, 2021) | 4 Nov 2026 | 8 names · Unlock |
| NewVale Capital | VC firm | Boulder, CO | Growth | Medtech, Biotech, Healthtech | New fund, Oct 2026 | $250M (SEC Form D, 2026) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Quartus | VC firm | New York, NY | Growth | Medtech, AI, Healthtech, B2B | New fund, Sep 2026 | $150M (SEC Form D, 2026) | 4 Nov 2026 | 8 names, firm email · Unlock |
| HLM Investment Partners | VC firm | Waltham, MA | Growth | Medtech, Healthtech | New fund, Aug 2026 | $61M (SEC Form D, 2025) | 4 Nov 2026 | 4 names · Unlock |
| Accelmed | VC firm | Aventura, FL | Growth | Medtech, Healthtech, Developer Tools, Biotech | Portfolio news, Apr 2026 | $401M (SEC Form D, 2021) | 5 Nov 2026 | 8 names, firm email · Unlock |
| Arcventis Health Partners | VC firm | New York, NY | Growth | Medtech, Healthtech, Biotech | New fund, Sep 2026 | $33M (SEC Form D, 2025) | 4 Nov 2026 | 4 names, firm email · Unlock |
| Claritas Signal Partners | VC firm | Nashville, TN | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Media | New deal, Aug 2026 | $14M (SEC Form D, 2021) | 5 Nov 2026 | 8 names · Unlock |
| Sana Capital | VC firm | New York, NY | Growth | Medtech, Healthtech | New fund, Apr 2026 | $100M (SEC Form D, 2026) | 4 Nov 2026 | 5 names · Unlock |
| Ansa | VC firm | New York, NY | Series A, Series B, Growth | Medtech, AI, Cybersecurity, Healthtech | New fund, May 2026 | $200M (SEC Form D, 2026) | 4 Nov 2026 | 4 names, firm email · Unlock |
| Sprig Equity | VC firm | Wilmette, IL | Growth, Late stage | Medtech, Healthtech | New fund, Aug 2026 | $34M (SEC Form D, 2023) | 5 Nov 2026 | 6 names, firm email · Unlock |
| Eckuity Capital | VC firm | New York, NY | Growth | Medtech, Healthtech, Biotech | New fund, Jun 2026 | $300M (SEC Form D, 2026) | 4 Nov 2026 | 1 name · Unlock |
| Aliment Capital | VC firm | Los Angeles, CA | Growth | Medtech, Healthtech, Food and Beverage, Agritech | Portfolio news, Mar 2026 | $413M (SEC Form ADV) | 5 Nov 2026 | LinkedIn page · Unlock |
| Adams Street Growth Equity | Fund manager | Chicago, IL | Growth | Medtech, SaaS, Fintech | New fund, Apr 2026 | $167M (SEC Form D, 2023) | 4 Nov 2026 | 8 names · Unlock |
| Star51 Capital | VC firm | New York, NY | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Robotics | New deal, Sep 2026 | 4 Nov 2026 | 3 names, firm email · Unlock | |
| Sandbox Clinical Ventures | VC firm | Chicago, IL | Seed, Series A, Series B, Growth | Medtech, Insurtech, Healthtech, AI | New fund, Sep 2026 | $100M (SEC Form D, 2021) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Roo Capital | VC firm | Coconut Grove, FL | Pre-seed, Seed, Series A, Growth | Medtech, AI, Healthtech, Future of Work | New fund, Aug 2026 | $125M (SEC Form D, 2026) | 4 Nov 2026 | 8 names, firm email · Unlock |
You are seeing 25 of 69. The full list adds 44 more investors and 383 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
How these 69 break down
By US state
| US state | On this list | Share |
|---|---|---|
| California | 14 | 20% |
| New York | 9 | 13% |
| Massachusetts | 8 | 12% |
| Florida | 5 | 7% |
| Texas | 4 | 6% |
| Illinois | 3 | 4% |
| Connecticut | 3 | 4% |
| Tennessee | 2 | 3% |
| Washington | 2 | 3% |
| Maryland | 2 | 3% |
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 64 | 93% |
| Corporate VC | 3 | 4% |
| Fund manager | 2 | 3% |
Method and limits
- Source
- All 69 rows carry an SEC filing (Form D or Form ADV). All 69 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states medtech and medical devices as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at growth-stage.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (30: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (20; half of that when the sector is stated only), stage focus (15: all of it when growth-stage is the only stage the firm states, split evenly when it states more), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (12) and completeness of the public record (8). Stage and regional focus are our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 6 Nov 2026.
- Fill rates
- Of 69 rows: stage 69, sector 69, fund size 61, website 69. In the paid file: named decision-makers on 64 rows, firm email on 25, LinkedIn page on 41, check size on 6.
- Corrections
- Email [email protected] or use the update form. We act within 5 working days.
Questions
How many growth-stage medtech investors in the US are there?
We list 69 as of November 2026. 33 of the 69 have a fund filing or a dated deal in the last 12 months. The cities with the most are New York (9), Boston (5) and Menlo Park (4).
Which growth-stage medtech investors in the US raised a new fund in the last 12 months?
21 of the 69 have a fund filing dated in the last 12 months. The most recent on this list are IVP: Venture capital for the Exceptional (Oct 2026), NewVale Capital (Oct 2026) and Transformation Capital (Sep 2026).
What is the typical fund size of growth-stage medtech investors in the US?
The median fund size on file for this list is $150M, across the 45 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 24 do not disclose a size there.
How do I contact growth-stage medtech investors in the US?
The paid file holds 383 named decision-makers across 64 of these 69 and a firm email for 25. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.
Where does the data on growth-stage medtech investors in the US come from?
All 69 rows have an SEC filing on file (Form D or Form ADV). Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 6 Nov 2026 at the latest. The whole file is re-verified twice a year.
Broader lists
Medtech venture capital firms in the US (350)Growth-stage investors in the US (288)Growth-stage medtech investors (107)
Related lists
Seed medtech investors in the US (205)Growth-stage AI investors in the US (162)Growth-stage SaaS investors in the US (162)Growth-stage healthtech investors in the US (121)Growth-stage fintech investors in the US (97)Pre-seed medtech investors in the US (95)Series A medtech investors in the US (76)Growth-stage consumer investors in the US (60)Growth-stage cybersecurity investors in the US (55)Growth-stage B2B investors in the US (54)Growth-stage biotech investors in the US (44)Growth-stage deep tech investors in the US (43)Growth-stage energy investors in the US (42)Series B medtech investors in the US (36)Growth-stage hardware investors in the US (36)Growth-stage industrial tech investors in the US (35)Growth-stage climate tech investors in the US (34)Growth-stage developer tools investors in the US (24)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to medtech and medical devices, growth-stage and the US. Guide: how many investors to pitch. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.